Loading…
Distinct Kinetics for Binding of the CD46 and SLAM Receptors to Overlapping Sites in the Measles Virus Hemagglutinin Protein
Measles virus (MV) is a human pathogen using two distinct cell surface receptors for entry into host cells. We present here a comparative analysis for binding of the MV receptors CD46 and SLAM to the measles virus hemagglutinin protein (MVH, Edmonston strain). Soluble monomeric and dimeric MVH varia...
Saved in:
Published in: | The Journal of biological chemistry 2002-08, Vol.277 (35), p.32294-32301 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Measles virus (MV) is a human pathogen using two distinct cell surface receptors for entry into host cells. We present here
a comparative analysis for binding of the MV receptors CD46 and SLAM to the measles virus hemagglutinin protein (MVH, Edmonston
strain). Soluble monomeric and dimeric MVH variants were prepared in mammalian cells and their conformation assessed using
a panel of monoclonal antibodies. The two receptor molecules specifically bound to the MVH protein with distinct binding modes.
The association rate ( k
a ) for SLAM binding to MVH was very low (â¼3000 m
â1 s â1 ), about 20 times lower that the k
a determined for CD46 binding. However, SLAM bound tighter to the virus protein than CD46, as revealed by a 5-fold lower dissociation
rate ( k
d , â¼1.5 Ã 10 â3 s â1 ). These data suggest that the SLAM receptor binds to a less accessible and more hydrophobic surface on MVH than the CD46
receptor, as illustrated in a binding model. Despite the differences in kinetics, receptor competition binding experiments
revealed that they recognize overlapping sites in MVH. Indeed, a panel of anti-MVH monoclonal antibodies equally inhibited
binding of both receptor molecules. The similar immune reactivity of the two receptor binding sites suggests that the shift
in receptor usage by MV may not be driven by immune responses. |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M202973200 |